Merck Serono S.A.S.
Merck Serono commercializes the group's branded prescription drug products in France. These patented medicines are the result of Merck's own research and partnerships. Merck Serono offers product ranges in several therapeutic classes.
| Facts & Figures | |
| President | Pierre-Henry Longeray |
| Number of employees | 266 |
| Sales | 520,8 million € in 2009 |
| Key therapeutic areas and products | Oncology: treatment of cancers (Erbitux®, UFT®)
Neurology: multiple sclerosis (Rebif®) Fertility: treatment of infertilty (GONAL-F®, Cetrotide®, Luveris®, Ovitrelle®) Endocrinology: treatment of growth hormone disorders (Saizen®) CardioMetabolic Care: diabetes (Glucophage® family), cardiovascular diseases (Concor®, Adancor®, Fozitec®), thyroid disorders (Levothyrox®), Dermatology: psoriasis (Apsor®), fungal treatments (Amycor®) Emergency products: treatment of cyanure poisioning (Cyanokit®) Alcohology: treatment of alcohol dependence (Campral®) |
